N
Name | Dosage form | ATC code |
---|---|---|
![]() Acetylsalicylic acid Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg № 10 | N02BA01 |
![]() Alzhmerat Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
600 mg/7 ml № 10 | N07A X02 |
![]() Alzhmerat Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
250 mg/ml, 4 ml № 5, № 10, № 100 | N07AX02 |
![]() Amitriptylline Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
25 mg № 50, № 1000 | N06AA09 |
![]() Analgin Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg/ml, 2 ml № 10 | N02BB02 |
![]() Analgin for children Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,1 g № 10 | N02BB02 |
![]() Analgin for children Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,25 g № 10 | N02BB02 |
![]() Azaleptol Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
100 mg №50 | N05AH02 |
![]() Azaleptol Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
25 mg № 50 | N05AH02 |
![]() Barviton Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml, 2 ml № 10 | N06BX18 |
![]() Carbamazepine Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg №20 | N03AF01 |
![]() Carbamazepine Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg № 50 | N03AF01 |
![]() Cilityn Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
250 mg/ml, 4 ml № 5, № 10, № 100 | N06BX06 |
![]() Cinnarizine Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,025 g № 25, № 50 | N07CA02 |
![]() Cylityne Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
100 mg, 30 ml | N06BX06 |
![]() Epigaba Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
300 mg №100 | N03AX12 |
![]() Epigaba Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
300 mg № 20 | N03AX12 |
![]() Ipidacord Solution for injections Pharmacotherapeutic group Agents affecting the nervous system |
15 mg/ml 1 ml №10 | N07АА |
![]() Ipidacord Solution for injections Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml 1 ml №10, №100 | N07АА |
|
150 мг №21 | N03A X16 |
|
150 mg №56 | N03A X16 |
|
300 мг №21 | N03A X16 |
|
300 mg №56 | N03A X16 |
|
75 мг №21 | N03A X16 |
|
75 mg №56 | N03A X16 |
![]() Leknizine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,025 g № 10, № 50 | N07CA02 |
|
200 mg №50 | N03A F01 |
![]() Lidocaine Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
20 mg/ml, 2 ml in ampoules № 10 | N01BB02 |
![]() Lidocaine Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml, 3,5 ml № 10 | N01BВ02 |
![]() Nalbuphine Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml 1 ml №10 | N02AF02 |
![]() Nalbuphine Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml 2 ml №5 | N02AF02 |
![]() Novocaine Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml, 5 ml № 10 | N01BA02 |
![]() Paracetamol Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg №10, №20, №50 | N02B E01 |
![]() Piracetam Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg/mg, 5 ml № 10 | N06BX03 |
![]() Tet 36.6 RAPID with acacia flavour Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
![]() Tet 36.6 RAPID with lemon flavour Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
![]() Tеt 36.6 MAXI with lemon flavour Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
![]() Tеt 36.6 MAXI with raspberry flavour Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BE51 |
![]() Tеt 36.6 with acacia flavour Powder for oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
13,1 g № 5, № 10 | N02BE51 |
![]() Venocor Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
50 mg/ml 2 ml № 10 | N07XX |
![]() Venocor Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
50 mg/ml, 5 ml № 5 | N07XX |
![]() Vinpocetin Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,005 g № 30, № 50 | N06BX18 |